10002-29-6

Usage

Uses

Used in Organic Synthesis:
(Pyridin-2-ylsulfanyl)-acetic acid is used as a building block or intermediate in the synthesis of various organic compounds. Its unique structure, featuring a pyridine ring and a sulfanyl group, allows for versatile chemical reactions and the formation of diverse products.
Used in Pharmaceutical Industry:
(Pyridin-2-ylsulfanyl)-acetic acid may be used as a precursor or active pharmaceutical ingredient in the development of new drugs. Its potential biological activity and ability to form stable complexes with other molecules make it a promising candidate for medicinal chemistry research.
Used in Chemical Research:
As a relatively less researched chemical, (Pyridin-2-ylsulfanyl)-acetic acid can be used in various chemical research applications to explore its properties, reactivity, and potential applications. This may include studies on its synthesis, stability, and interactions with other chemical compounds.

Upstream product

• 2637-34-5 2-Sulfanylpyridine 
• 109-09-1 2-chloropyridine 
• 68-11-1 mercaptoacetic acid 
• 79-08-3 bromoacetic acid 
• 114086-04-3 (pyridin-2-ylsulfanyl)-acetic acid methyl ester 

Downstream Products

• 68840-18-6 2-(4-nitro-phenylhydrazono)-3-oxo-2,3-dihydro-thiazolo[3,2-a]pyridinylium betaine 
• 68840-21-1 2-[hydroxy-(4-nitro-phenyl)-methyl]-3-oxo-2,3-dihydro-thiazolo[3,2-a]pyridinylium betaine 
• 66102-82-7 3-oxo-2-(pyridin-2-ylsulfanyl-acetyl)-2,3-dihydro-thiazolo[3,2-a]pyridinylium betaine 
• 80484-79-3 C₁₆H₁₁NO₂S 
• 80484-85-1 C₁₄H₉NO₂S 
• 80484-84-0 C₁₄H₁₀N₂O₂S 
• 10273-89-9 2-(2-methylphenyl)pyridine 
• 72006-93-0 3-oxo-2-(pyridin-2-ylsulfanyl-thioacetyl)-2,3-dihydro-thiazolo[3,2-a]pyridinylium betaine 
• 80484-77-1 anhydro-2-<2-(phenylsulfinyl)acetyl>-3-hydroxythiazolo<3,2-a>pyridinium hydroxide 
• 80484-76-0 anhydro-2-<2-(phenylthio)acetyl>-3-hydroxythiazolo<3,2-a>pyridinium hydroxide 

Relevant academic research and scientific papers

Screening of ligands for the Ullmann synthesis of electron-rich diaryl ethers

In the search for new ligands for the Ullmann diaryl ether synthesis, permitting the coupling of electron-rich aryl bromides at relatively low temperatures, 56 structurally diverse multidentate ligands were screened in a model system that uses copper iodide in acetonitrile with potassium phosphate as the base. The ligands differed largely in their performance, but no privileged structural class could be identified.

INTEGRASE INHIBITORS - 2

The present invention provides a method of treatment or prophylaxis of a viral infection in a subject comprising administering to said subject an effective amount of a compound of formula (I) or a pharmaceutically acceptable derivative, salt or prodrug thereof. Compounds of formula (I) are also provided.

CHEMOKINE RECEPTOR BINDING COMPOUNDS

The present invention relates to chemokine receptor binding compounds, pharmaceutical compositions and their use. More specifically, the present invention relates to modulators of chemokine receptor activity, preferably modulators of CCR5. Thesd compounds demonstrate protective effects against infection of target cells by a human immunodeficiency virus (HIV).